title: Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation.
abstract: Oct4 is critical to maintain the pluripotency of human embryonic stem cells (hESCs); however, the underlying mechanism remains to be fully understood. Here, we report that silencing of Oct4 in hESCs leads to the activation of tumor suppressor p53, inducing the differentiation of hESCs since acute disruption of p53 in p53 conditional knockout (p53CKO) hESCs prevents the differentiation of hESCs after Oct4 depletion. We further discovered that the silencing of Oct4 significantly reduces the expression of Sirt1, a deacetylase known to inhibit p53 activity and the differentiation of ESCs, leading to increased acetylation of p53 at lysine 120 and 164. The importance of Sirt1 in mediating Oct4-dependent pluripotency is revealed by the finding that the ectopic expression of Sirt1 in Oct4-silenced hESCs prevents p53 activation and hESC differentiation. In addition, using knock-in approach, we revealed that the acetylation of p53 at lysine 120 and 164 is required for both stabilization and activity of p53 in hESCs. In summary, our findings reveal a novel role of Oct4 in maintaining the pluripotency of hESCs by suppressing pathways that induce differentiation. Considering that p53 suppresses pluripotency after DNA damage response in ESCs, our findings further underscore the stringent mechanism to coordinate DNA damage response pathways and pluripotency pathways in order to maintain the pluripotency and genomic stability of hESCs.
authors.affiliation: Section of Molecular Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, California, USA.
authors.forename: Zhen-Ning
authors.initials: ZN
authors.lastname: Zhang
authors.forename: Sun-Ku
authors.initials: SK
authors.lastname: Chung
authors.forename: Zheng
authors.initials: Z
authors.lastname: Xu
authors.forename: Yang
authors.initials: Y
authors.lastname: Xu
mesh_terms: D000107:Acetylation; D018929:Cell Culture Techniques; D002454:Cell Differentiation / Q000502:physiology; D004249:DNA Damage; D053595:Embryonic Stem Cells / Q000166:cytology / Q000378:metabolism*; D055786:Gene Knockout Techniques; D006801:Humans; D050814:Octamer Transcription Factor-3 / Q000235:genetics / Q000378:metabolism*; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000378:metabolism*; D056564:Sirtuin 1 / Q000378:metabolism*; D014162:Transfection; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: D050814:Octamer Transcription Factor-3; C494173:POU5F1 protein, human; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; C447939:SIRT1 protein, human; D056564:Sirtuin 1
keywords: Acetylation; DNA damage response; Differentiation; Human ESCs; Pluripotency; p53
references.citation: Nature. 2009 Aug 27;460(7259):1149-53
references.pmid: 19668189
references.citation: Cell. 2008 Nov 28;135(5):907-18
references.pmid: 19041753
references.citation: Mol Cell. 2006 Dec 28;24(6):827-39
references.pmid: 17189186
references.citation: Nature. 2009 Aug 27;460(7259):1145-8
references.pmid: 19668190
references.citation: Cell. 2009 May 1;137(3):413-31
references.pmid: 19410540
references.citation: Cell. 2008 May 16;133(4):612-26
references.pmid: 18485870
references.citation: Nature. 2009 Nov 19;462(7271):315-22
references.pmid: 19829295
references.citation: Nucleic Acids Res. 2012 Sep 1;40(17):8199-209
references.pmid: 22730289
references.citation: Cell. 2008 Jun 13;133(6):1106-17
references.pmid: 18555785
references.citation: Cell. 2012 Jun 8;149(6):1269-83
references.pmid: 22682249
references.citation: PLoS Biol. 2012;10(2):e1001268
references.pmid: 22389628
references.citation: PLoS One. 2012;7(6):e39896
references.pmid: 22768158
references.citation: J Mol Med (Berl). 2010 Oct;88(10):981-6
references.pmid: 20809088
references.citation: Genes Dev. 2003 Aug 15;17(16):2048-59
references.pmid: 12923055
references.citation: Nat Cell Biol. 2010 Oct;12(10):993-8
references.pmid: 20818388
references.citation: Annu Rev Biochem. 2004;73:417-35
references.pmid: 15189148
references.citation: Nature. 2009 Aug 27;460(7259):1140-4
references.pmid: 19668186
references.citation: Cell Res. 2010 Jun;20(6):614-21
references.pmid: 20404858
references.citation: Cell. 2005 May 6;121(3):465-77
references.pmid: 15882627
references.citation: Cell. 2001 Oct 19;107(2):149-59
references.pmid: 11672523
references.citation: Trends Biochem Sci. 2012 Aug;37(8):317-24
references.pmid: 22626470
references.citation: Cell. 2001 Oct 19;107(2):137-48
references.pmid: 11672522
references.citation: Cell Stem Cell. 2008 Mar 6;2(3):241-51
references.pmid: 18371449
references.citation: Nature. 2009 Aug 27;460(7259):1132-5
references.pmid: 19668191
references.citation: Trends Cell Biol. 2010 Mar;20(3):170-5
references.pmid: 20061153
references.citation: Cell. 1998 Oct 30;95(3):379-91
references.pmid: 9814708
references.citation: Cancer Cell. 2003 Nov;4(5):361-70
references.pmid: 14667503
references.citation: Nature. 2009 Aug 27;460(7259):1136-9
references.pmid: 19668188
references.citation: Cell Stem Cell. 2010 Jan 8;6(1):80-9
references.pmid: 20074536
references.citation: Nat Genet. 2008 May;40(5):499-507
references.pmid: 18443585
references.citation: Cell. 2009 Apr 3;137(1):13-7
references.pmid: 19345179
references.citation: Mol Cell. 2006 Dec 28;24(6):841-51
references.pmid: 17189187
references.citation: Cell. 1997 Aug 22;90(4):595-606
references.pmid: 9288740
references.citation: Nat Genet. 2000 Apr;24(4):372-6
references.pmid: 10742100
references.citation: Mol Cell Biol. 1999 Feb;19(2):1202-9
references.pmid: 9891054
references.citation: Curr Opin Genet Dev. 2012 Oct;22(5):409-15
references.pmid: 22922161
references.citation: Nat Cell Biol. 2005 Feb;7(2):165-71
references.pmid: 15619621